
Optimised active substances against RSV
OPERA research project launched to further develop antiviral active substances
Inaugural lecture on 6 March 2026

Since January 2026, TWINCORE has a new full faculty member: Prof. Marco Galardini has been appointed W2 professor at the Hannover Medical School. For the past five years, he had been funded by the RESIST Cluster of Excellence. After the positive evaluation of his research activities, he can now continue his work in Hannover.
Marco Galardini is a computational biologist with a strong interest in microbiology. His work group “Systems Biology of Microbial Communities” at TWINCORE is focussing on microbial pangenomes. He is interested in understanding how genetic variants between bacterial strains relate to phenotypic variability, both generally and in the context of infection. Evolution of antimicrobial resistance and its dependency on microbial pangenomes is also a research area in the lab.
Galardini did his bachelor and master studies in Italy at the university of Florence and Bologna, and his PhD in the lab of Marco Bazzicalupo. He then did two postdocs: one in the lab of Pedro Beltrao at EMBL-EBI, and one in the lab of Mo Khalil at Boston University. He leads the Microbial Pangenomes Lab at TWINCORE since October 2020.
Friday, 6 March 2026, 15:00

OPERA research project launched to further develop antiviral active substances

Some extension numbers have changed.

zukunft.niedersachsen provides €2.7 million in funding for joint project on rare diseases